CONAGRA BRANDS INC (CAG) Fundamental Analysis & Valuation

NYSE:CAG • US2058871029

Current stock price

15.5699 USD
+0.01 (+0.06%)
Last:

This CAG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CAG Profitability Analysis

1.1 Basic Checks

  • CAG had positive earnings in the past year.
  • CAG had a positive operating cash flow in the past year.
  • In the past 5 years CAG has always been profitable.
  • Each year in the past 5 years CAG had a positive operating cash flow.
CAG Yearly Net Income VS EBIT VS OCF VS FCFCAG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.50%, CAG is in line with its industry, outperforming 40.23% of the companies in the same industry.
  • CAG's Return On Equity of -1.21% is in line compared to the rest of the industry. CAG outperforms 40.23% of its industry peers.
  • The Return On Invested Capital of CAG (6.94%) is better than 73.56% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CAG is in line with the industry average of 7.17%.
Industry RankSector Rank
ROA -0.5%
ROE -1.21%
ROIC 6.94%
ROA(3y)3.42%
ROA(5y)4.02%
ROE(3y)8.28%
ROE(5y)10.03%
ROIC(3y)7.92%
ROIC(5y)7.78%
CAG Yearly ROA, ROE, ROICCAG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • In the last couple of years the Profit Margin of CAG has grown nicely.
  • The Operating Margin of CAG (12.86%) is better than 87.36% of its industry peers.
  • CAG's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CAG (24.57%) is better than 60.92% of its industry peers.
  • In the last couple of years the Gross Margin of CAG has declined.
Industry RankSector Rank
OM 12.86%
PM (TTM) N/A
GM 24.57%
OM growth 3Y-1.53%
OM growth 5Y-3%
PM growth 3Y8.84%
PM growth 5Y5.48%
GM growth 3Y1.42%
GM growth 5Y-1.64%
CAG Yearly Profit, Operating, Gross MarginsCAG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CAG Health Analysis

2.1 Basic Checks

  • CAG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CAG remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CAG has less shares outstanding
  • Compared to 1 year ago, CAG has an improved debt to assets ratio.
CAG Yearly Shares OutstandingCAG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CAG Yearly Total Debt VS Total AssetsCAG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • CAG has an Altman-Z score of 1.61. This is a bad value and indicates that CAG is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.61, CAG perfoms like the industry average, outperforming 43.68% of the companies in the same industry.
  • The Debt to FCF ratio of CAG is 8.70, which is on the high side as it means it would take CAG, 8.70 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CAG (8.70) is better than 60.92% of its industry peers.
  • CAG has a Debt/Equity ratio of 0.85. This is a neutral value indicating CAG is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CAG (0.85) is worse than 65.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 8.7
Altman-Z 1.61
ROIC/WACC0.99
WACC7.03%
CAG Yearly LT Debt VS Equity VS FCFCAG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • CAG has a Current Ratio of 0.89. This is a bad value and indicates that CAG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.89, CAG is doing worse than 75.86% of the companies in the same industry.
  • A Quick Ratio of 0.28 indicates that CAG may have some problems paying its short term obligations.
  • CAG has a worse Quick ratio (0.28) than 87.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.28
CAG Yearly Current Assets VS Current LiabilitesCAG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CAG Growth Analysis

3.1 Past

  • CAG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.51%.
  • CAG shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.17% yearly.
  • CAG shows a decrease in Revenue. In the last year, the revenue decreased by -5.82%.
  • CAG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.99% yearly.
EPS 1Y (TTM)-24.51%
EPS 3Y-0.99%
EPS 5Y0.17%
EPS Q2Q%-35.71%
Revenue 1Y (TTM)-5.82%
Revenue growth 3Y0.22%
Revenue growth 5Y0.99%
Sales Q2Q%-6.76%

3.2 Future

  • Based on estimates for the next years, CAG will show a decrease in Earnings Per Share. The EPS will decrease by -1.00% on average per year.
  • The Revenue is expected to decrease by -0.05% on average over the next years.
EPS Next Y-24.31%
EPS Next 2Y-10.95%
EPS Next 3Y-5.24%
EPS Next 5Y-1%
Revenue Next Year-3.82%
Revenue Next 2Y-2.37%
Revenue Next 3Y-1.2%
Revenue Next 5Y-0.05%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CAG Yearly Revenue VS EstimatesCAG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
CAG Yearly EPS VS EstimatesCAG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. CAG Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.15, the valuation of CAG can be described as reasonable.
  • Based on the Price/Earnings ratio, CAG is valued cheaper than 89.66% of the companies in the same industry.
  • CAG's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.79.
  • Based on the Price/Forward Earnings ratio of 8.54, the valuation of CAG can be described as reasonable.
  • 95.40% of the companies in the same industry are more expensive than CAG, based on the Price/Forward Earnings ratio.
  • CAG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.80.
Industry RankSector Rank
PE 8.15
Fwd PE 8.54
CAG Price Earnings VS Forward Price EarningsCAG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 67.82% of the companies in the same industry are more expensive than CAG, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CAG is valued cheaply inside the industry as 87.36% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.5
EV/EBITDA 7.99
CAG Per share dataCAG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • CAG's earnings are expected to decrease with -5.24% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)46.63
EPS Next 2Y-10.95%
EPS Next 3Y-5.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. CAG Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 8.66%, CAG is a good candidate for dividend investing.
  • CAG's Dividend Yield is rather good when compared to the industry average which is at 2.46. CAG pays more dividend than 95.40% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, CAG pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.66%

5.2 History

  • On average, the dividend of CAG grows each year by 10.50%, which is quite nice.
  • CAG has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CAG has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.5%
Div Incr Years5
Div Non Decr Years17
CAG Yearly Dividends per shareCAG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • CAG has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-682.55%
EPS Next 2Y-10.95%
EPS Next 3Y-5.24%
CAG Yearly Income VS Free CF VS DividendCAG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

More info and screens

Find the best dividend stocksShow peers with best dividend

CAG Fundamentals: All Metrics, Ratios and Statistics

CONAGRA BRANDS INC

NYSE:CAG (3/19/2026, 11:20:04 AM)

15.5699

+0.01 (+0.06%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)12-19
Earnings (Next)04-01
Inst Owners87%
Inst Owner Change-2.56%
Ins Owners0.64%
Ins Owner Change0.05%
Market Cap7.45B
Revenue(TTM)11.23B
Net Income(TTM)-98.00M
Analysts55.2
Price Target19.98 (28.32%)
Short Float %6.72%
Short Ratio2.38
Dividend
Industry RankSector Rank
Dividend Yield 8.66%
Yearly Dividend1.4
Dividend Growth(5Y)10.5%
DP-682.55%
Div Incr Years5
Div Non Decr Years17
Ex-Date01-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.92%
Min EPS beat(2)2.06%
Max EPS beat(2)15.78%
EPS beat(4)2
Avg EPS beat(4)2.26%
Min EPS beat(4)-4.48%
Max EPS beat(4)15.78%
EPS beat(8)5
Avg EPS beat(8)1.24%
EPS beat(12)9
Avg EPS beat(12)3.66%
EPS beat(16)12
Avg EPS beat(16)4.63%
Revenue beat(2)0
Avg Revenue beat(2)-0.72%
Min Revenue beat(2)-1.13%
Max Revenue beat(2)-0.32%
Revenue beat(4)0
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-3.1%
Max Revenue beat(4)-0.32%
Revenue beat(8)1
Avg Revenue beat(8)-1.52%
Revenue beat(12)1
Avg Revenue beat(12)-1.59%
Revenue beat(16)3
Avg Revenue beat(16)-1.15%
PT rev (1m)0.57%
PT rev (3m)-5.29%
EPS NQ rev (1m)-0.14%
EPS NQ rev (3m)-6.05%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)-1.69%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0.87%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.15
Fwd PE 8.54
P/S 0.66
P/FCF 8.5
P/OCF 5.87
P/B 0.92
P/tB N/A
EV/EBITDA 7.99
EPS(TTM)1.91
EY12.27%
EPS(NY)1.82
Fwd EY11.71%
FCF(TTM)1.83
FCFY11.77%
OCF(TTM)2.65
OCFY17.04%
SpS23.48
BVpS16.91
TBVpS-8.03
PEG (NY)N/A
PEG (5Y)46.63
Graham Number26.96
Profitability
Industry RankSector Rank
ROA -0.5%
ROE -1.21%
ROCE 9.08%
ROIC 6.94%
ROICexc 6.96%
ROICexgc 26.13%
OM 12.86%
PM (TTM) N/A
GM 24.57%
FCFM 7.8%
ROA(3y)3.42%
ROA(5y)4.02%
ROE(3y)8.28%
ROE(5y)10.03%
ROIC(3y)7.92%
ROIC(5y)7.78%
ROICexc(3y)7.95%
ROICexc(5y)7.81%
ROICexgc(3y)32.64%
ROICexgc(5y)34.56%
ROCE(3y)10.57%
ROCE(5y)10.3%
ROICexgc growth 3Y-5.95%
ROICexgc growth 5Y-11.19%
ROICexc growth 3Y1.74%
ROICexc growth 5Y-0.82%
OM growth 3Y-1.53%
OM growth 5Y-3%
PM growth 3Y8.84%
PM growth 5Y5.48%
GM growth 3Y1.42%
GM growth 5Y-1.64%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 8.7
Debt/EBITDA 3.74
Cap/Depr 101.71%
Cap/Sales 3.49%
Interest Coverage 250
Cash Conversion 69.31%
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.28
Altman-Z 1.61
F-Score5
WACC7.03%
ROIC/WACC0.99
Cap/Depr(3y)98.17%
Cap/Depr(5y)109.76%
Cap/Sales(3y)3.17%
Cap/Sales(5y)3.62%
Profit Quality(3y)224.76%
Profit Quality(5y)165.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.51%
EPS 3Y-0.99%
EPS 5Y0.17%
EPS Q2Q%-35.71%
EPS Next Y-24.31%
EPS Next 2Y-10.95%
EPS Next 3Y-5.24%
EPS Next 5Y-1%
Revenue 1Y (TTM)-5.82%
Revenue growth 3Y0.22%
Revenue growth 5Y0.99%
Sales Q2Q%-6.76%
Revenue Next Year-3.82%
Revenue Next 2Y-2.37%
Revenue Next 3Y-1.2%
Revenue Next 5Y-0.05%
EBIT growth 1Y-22.26%
EBIT growth 3Y-1.31%
EBIT growth 5Y-2.04%
EBIT Next Year4.75%
EBIT Next 3Y3.39%
EBIT Next 5Y4.56%
FCF growth 1Y-24.69%
FCF growth 3Y22.29%
FCF growth 5Y-2.41%
OCF growth 1Y-18.21%
OCF growth 3Y12.88%
OCF growth 5Y-1.68%

CONAGRA BRANDS INC / CAG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CONAGRA BRANDS INC?

ChartMill assigns a fundamental rating of 4 / 10 to CAG.


What is the valuation status of CONAGRA BRANDS INC (CAG) stock?

ChartMill assigns a valuation rating of 6 / 10 to CONAGRA BRANDS INC (CAG). This can be considered as Fairly Valued.


What is the profitability of CAG stock?

CONAGRA BRANDS INC (CAG) has a profitability rating of 5 / 10.


What is the valuation of CONAGRA BRANDS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CONAGRA BRANDS INC (CAG) is 8.15 and the Price/Book (PB) ratio is 0.92.


Can you provide the financial health for CAG stock?

The financial health rating of CONAGRA BRANDS INC (CAG) is 3 / 10.